chrX-12885540-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016562.4(TLR7):c.32A>T(p.Gln11Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 1,202,693 control chromosomes in the GnomAD database, including 17,131 homozygotes. There are 75,300 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_016562.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLR7 | NM_016562.4 | c.32A>T | p.Gln11Leu | missense_variant | 3/3 | ENST00000380659.4 | NP_057646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLR7 | ENST00000380659.4 | c.32A>T | p.Gln11Leu | missense_variant | 3/3 | 1 | NM_016562.4 | ENSP00000370034 | P1 |
Frequencies
GnomAD3 genomes AF: 0.181 AC: 20199AN: 111447Hom.: 1402 Cov.: 23 AF XY: 0.176 AC XY: 5933AN XY: 33639
GnomAD3 exomes AF: 0.178 AC: 31777AN: 178823Hom.: 2171 AF XY: 0.176 AC XY: 11187AN XY: 63623
GnomAD4 exome AF: 0.198 AC: 216392AN: 1091191Hom.: 15730 Cov.: 29 AF XY: 0.194 AC XY: 69366AN XY: 357607
GnomAD4 genome AF: 0.181 AC: 20191AN: 111502Hom.: 1401 Cov.: 23 AF XY: 0.176 AC XY: 5934AN XY: 33704
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied by a panel of primary immunodeficiencies. Number of patients: 23. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at